Filing Details

Accession Number:
0001371285-21-000236
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-05 18:58:35
Reporting Period:
2021-08-03
Accepted Time:
2021-08-05 18:58:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1371285 Trupanion Inc. TRUP Hospital & Medical Service Plans (6324) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611679 Darryl Rawlings C/O Trupanion, Inc.
6100 4Th Avenue South, Suite 200
Seattle WA 98108
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-08-03 4,000 $113.83 987,222 No 4 S Indirect By Kuyashii Primary Equities LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Kuyashii Primary Equities LLC
Footnotes
  1. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by Kuyashii Primary Equities LLC. a limited liability company indirectly, wholly-owned by the reporting person and reporting person's spouse, on November 3, 2020, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. In aggregate, the reporting person's plan is Rule 10b5-1 trading plan is part of a diversification strategy on the part of the reporting person to diversify up to 25% of the reporting person's holdings as of the date of the Company's initial public offering in July 2014 from the inception of the Rule 10b5-1 trading plan through 2025.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.36 to $115.82 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).